Literature DB >> 20459575

Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours.

Stephane Boeuf1, Judith V M G Bovée, Burkhard Lehner, Pancras C W Hogendoorn, Wiltrud Richter.   

Abstract

AIMS: The molecular mechanisms underlying the progression of central chondrosarcoma are so far poorly understood. The aim of this study was to identify genes involved in the progression of these tumours by comparison of gene expression and correlation of expression profiles to histological grade and clinical outcome. METHODS AND
RESULTS: Array-based gene expression profiling of 19 chondrosarcoma samples was performed. Beside differences in the expression of cartilage matrix molecules, high-grade chondrosarcoma showed enhanced expression of the matrix metalloproteinase MMP-2 and of the hypoxia-inducible molecule galectin 1. Immunohistochemical analysis of galectin 1 and of further hypoxia-associated proteins was performed on 68 central and peripheral tumour samples. Hypoxia-inducible factor 1alpha (HIF-1alpha) activation was significantly elevated in high-grade central chondrosarcoma. A negative correlation of carbonic anhydrase IX expression to metastasis-free survival was independent of histological grade.
CONCLUSIONS: The expression patterns identified in this study point towards a substantial role for angiogenic and hypoxic signalling in chondrosarcoma progression. The constitutive activation of the transcription factor HIF-1alpha in high-grade chondrosarcoma could play a central role in the regulation of cell metabolism and vascularization in these tumours and may, for this reason, represent a potential target for chondrosarcoma therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20459575     DOI: 10.1111/j.1365-2559.2010.03528.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  20 in total

Review 1.  Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.

Authors:  Judith V M G Bovée; Pancras C W Hogendoorn; Jay S Wunder; Benjamin A Alman
Journal:  Nat Rev Cancer       Date:  2010-06-10       Impact factor: 60.716

Review 2.  Genetic alterations in chondrosarcomas - keys to targeted therapies?

Authors:  Andre M Samuel; Jose Costa; Dieter M Lindskog
Journal:  Cell Oncol (Dordr)       Date:  2014-01-24       Impact factor: 6.730

3.  Human osteoarthritic knee cartilage: fingerprinting of adhesion/growth-regulatory galectins in vitro and in situ indicates differential upregulation in severe degeneration.

Authors:  Stefan Toegel; Daniela Bieder; Sabine André; Klaus Kayser; Sonja M Walzer; Gerhard Hobusch; Reinhard Windhager; Hans-Joachim Gabius
Journal:  Histochem Cell Biol       Date:  2014-07-01       Impact factor: 4.304

4.  Expression profile of carbonic anhydrases in articular cartilage.

Authors:  Melissa Schultz; Wu Jin; Abdul Waheed; Berton R Moed; William Sly; Zijun Zhang
Journal:  Histochem Cell Biol       Date:  2011-07-08       Impact factor: 4.304

5.  An orthotopic mouse model for chondrosarcoma of bone provides an in vivo tool for drug testing.

Authors:  Jolieke G van Oosterwijk; Jacqueline R M Plass; Danielle Meijer; Ivo Que; Marcel Karperien; Judith V M G Bovée
Journal:  Virchows Arch       Date:  2014-10-21       Impact factor: 4.064

6.  miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis.

Authors:  Xiaojuan Sun; Cherie Charbonneau; Lei Wei; Qian Chen; Richard M Terek
Journal:  Mol Cancer Res       Date:  2015-05-26       Impact factor: 5.852

7.  Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer.

Authors:  David J Stewart; Maria I Nunez; Carmen Behrens; Diane Liu; Yan Heather Lin; J Jack Lee; Jack Roth; John Heymach; Stephen G Swisher; Waun Ki Hong; Ignacio Ivan Wistuba
Journal:  J Thorac Oncol       Date:  2014-05       Impact factor: 15.609

8.  The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets.

Authors:  E David; F Blanchard; M F Heymann; G De Pinieux; F Gouin; F Rédini; D Heymann
Journal:  Sarcoma       Date:  2011-05-22

9.  Prognostic impacts of hypoxic markers in soft tissue sarcoma.

Authors:  Eivind Smeland; Thomas K Kilvaer; Sveinung Sorbye; Andrej Valkov; Sigve Andersen; Roy M Bremnes; Lill-Tove Busund; Tom Donnem
Journal:  Sarcoma       Date:  2012-02-20

10.  BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors.

Authors:  Stephane Boeuf; Judith V M G Bovée; Burkhard Lehner; Brendy van den Akker; Maayke van Ruler; Anne-Marie Cleton-Jansen; Wiltrud Richter
Journal:  BMC Cancer       Date:  2012-10-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.